126 related articles for article (PubMed ID: 15887130)
1. Germline PMS2 mutations: one hit or two?
Gryfe R; Gallinger S
Gastroenterology; 2005 May; 128(5):1506-9. PubMed ID: 15887130
[No Abstract] [Full Text] [Related]
2. Germline mutation and protein expression analysis of mismatch repair genes MSH6 and PMS2 in Malaysian Lynch syndrome patients.
Zahary MN; Kaur G; Hassan MR; Sidek AS; Singh H; Yeh LY; Ankathil R
Int J Colorectal Dis; 2014 Feb; 29(2):261-2. PubMed ID: 24072394
[No Abstract] [Full Text] [Related]
3. Clearer picture of PMS2-associated lynch syndrome is emerging.
Daniels MS; Lu KH
J Clin Oncol; 2015 Feb; 33(4):299-300. PubMed ID: 25534383
[No Abstract] [Full Text] [Related]
4. PMS2 mutations in HNPCC.
Hayward BE; De Vos M; Sheridan E; Bonthron DT
Clin Genet; 2004 Dec; 66(6):566-7; author reply 568. PubMed ID: 15521988
[No Abstract] [Full Text] [Related]
5. Café-au-lait macules and pediatric malignancy caused by biallelic mutations in the DNA mismatch repair (MMR) gene PMS2.
Jackson CC; Holter S; Pollett A; Clendenning M; Chou S; Senter L; Ramphal R; Gallinger S; Boycott K
Pediatr Blood Cancer; 2008 Jun; 50(6):1268-70. PubMed ID: 18273873
[TBL] [Abstract][Full Text] [Related]
6. Establishing cancer risks associated with PMS2 germline mutations in Lynch syndrome.
Caron NS
Clin Genet; 2015 Jun; 87(6):533-4. PubMed ID: 25761717
[No Abstract] [Full Text] [Related]
7. Clinical problem-solving. Spot diagnosis.
Stark Z; Campbell LJ; Mitchell C; James PA; Heath JA; Boussioutas A; Lynch C; Trainer AH
N Engl J Med; 2014 Jun; 370(23):2229-36. PubMed ID: 24897087
[No Abstract] [Full Text] [Related]
8. Anticipating phenotypic differences from genetic mutations.
You YN
Dis Colon Rectum; 2015 Jan; 58(1):143-4. PubMed ID: 25489706
[No Abstract] [Full Text] [Related]
9. Mismatch repair gene deficiency and genetic anticipation in Lynch syndrome: myth or reality?
Ponti G; Ruini C; Tomasi A
Dis Colon Rectum; 2015 Jan; 58(1):141-2. PubMed ID: 25489705
[No Abstract] [Full Text] [Related]
10. Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes.
Vaughn CP; Robles J; Swensen JJ; Miller CE; Lyon E; Mao R; Bayrak-Toydemir P; Samowitz WS
Hum Mutat; 2010 May; 31(5):588-93. PubMed ID: 20205264
[TBL] [Abstract][Full Text] [Related]
11. PMS2 involvement in patients suspected of Lynch syndrome.
Niessen RC; Kleibeuker JH; Westers H; Jager PO; Rozeveld D; Bos KK; Boersma-van Ek W; Hollema H; Sijmons RH; Hofstra RM
Genes Chromosomes Cancer; 2009 Apr; 48(4):322-9. PubMed ID: 19132747
[TBL] [Abstract][Full Text] [Related]
12. Phenotype associated with recessively inherited mutations in DNA mismatch repair (MMR) genes.
de Vos M; Hayward B; Bonthron DT; Sheridan E
Biochem Soc Trans; 2005 Aug; 33(Pt 4):718-20. PubMed ID: 16042583
[TBL] [Abstract][Full Text] [Related]
13. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.
Senter L; Clendenning M; Sotamaa K; Hampel H; Green J; Potter JD; Lindblom A; Lagerstedt K; Thibodeau SN; Lindor NM; Young J; Winship I; Dowty JG; White DM; Hopper JL; Baglietto L; Jenkins MA; de la Chapelle A
Gastroenterology; 2008 Aug; 135(2):419-28. PubMed ID: 18602922
[TBL] [Abstract][Full Text] [Related]
14. Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1.
Krüger S; Kinzel M; Walldorf C; Gottschling S; Bier A; Tinschert S; von Stackelberg A; Henn W; Görgens H; Boue S; Kölble K; Büttner R; Schackert HK
Eur J Hum Genet; 2008 Jan; 16(1):62-72. PubMed ID: 17851451
[TBL] [Abstract][Full Text] [Related]
15. Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.
ten Broeke SW; Brohet RM; Tops CM; van der Klift HM; Velthuizen ME; Bernstein I; Capellá Munar G; Gomez Garcia E; Hoogerbrugge N; Letteboer TG; Menko FH; Lindblom A; Mensenkamp AR; Moller P; van Os TA; Rahner N; Redeker BJ; Sijmons RH; Spruijt L; Suerink M; Vos YJ; Wagner A; Hes FJ; Vasen HF; Nielsen M; Wijnen JT
J Clin Oncol; 2015 Feb; 33(4):319-25. PubMed ID: 25512458
[TBL] [Abstract][Full Text] [Related]
16. Refining the role of PMS2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants.
Borràs E; Pineda M; Cadiñanos J; Del Valle J; Brieger A; Hinrichsen I; Cabanillas R; Navarro M; Brunet J; Sanjuan X; Musulen E; van der Klift H; Lázaro C; Plotz G; Blanco I; Capellá G
J Med Genet; 2013 Aug; 50(8):552-63. PubMed ID: 23709753
[TBL] [Abstract][Full Text] [Related]
17. High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families.
Brea-Fernández AJ; Cameselle-Teijeiro JM; Alenda C; Fernández-Rozadilla C; Cubiella J; Clofent J; Reñé JM; Anido U; Milá M; Balaguer F; Castells A; Castellvi-Bel S; Jover R; Carracedo A; Ruiz-Ponte C
Clin Genet; 2014 Jun; 85(6):583-8. PubMed ID: 23837913
[TBL] [Abstract][Full Text] [Related]
18. PMS2 mutations in childhood cancer.
Bonthron DT; Hayward BE; De Vos M; Sheridan E
Gut; 2005 Dec; 54(12):1821. PubMed ID: 16284300
[No Abstract] [Full Text] [Related]
19. Inactivation of DNA mismatch repair by variants of uncertain significance in the PMS2 gene.
Drost M; Koppejan H; de Wind N
Hum Mutat; 2013 Nov; 34(11):1477-80. PubMed ID: 24027009
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.
Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM
PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
